16-4332444-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032575.3(GLIS2):c.164C>T(p.Pro55Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,611,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. P55P) has been classified as Likely benign.
Frequency
Consequence
NM_032575.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLIS2 | NM_032575.3 | c.164C>T | p.Pro55Leu | missense_variant | 2/7 | ENST00000433375.2 | |
GLIS2 | NM_001318918.2 | c.164C>T | p.Pro55Leu | missense_variant | 3/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLIS2 | ENST00000433375.2 | c.164C>T | p.Pro55Leu | missense_variant | 2/7 | 1 | NM_032575.3 | P1 | |
GLIS2 | ENST00000262366.7 | c.164C>T | p.Pro55Leu | missense_variant | 3/8 | 2 | P1 | ||
PAM16 | ENST00000577031.5 | c.292-670G>A | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000411 AC: 10AN: 243424Hom.: 0 AF XY: 0.0000451 AC XY: 6AN XY: 133070
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1459206Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 725922
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
Nephronophthisis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 09, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with GLIS2-related conditions. This variant is present in population databases (rs775844299, ExAC 0.01%). This sequence change replaces proline with leucine at codon 55 of the GLIS2 protein (p.Pro55Leu). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and leucine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at